Determination of the UL of Leucine in Healthy Elderly Men
Determination of the Tolerable Upper Intake Level (UL) of Leucine in Healthy Elderly Men (70-75 Yrs)
1 other identifier
interventional
6
1 country
1
Brief Summary
Amino acid are the building blocks of the body's protein. Some amino acids, including leucine, cannot be made in the body and must be obtained from diet, these are called essential. With increase in age the body's muscle mass decrease and studies have suggested that dietary supplementation of leucine may have potential health benefits in elderly in regards to prevention of age related loss of lean muscle mass, and thus may help improve the quality of life in elderly. Currently, a safe upper dietary intake level of leucine has not been established for healthy elderly. Prior to exploring whether leucine supplementation will prevent or decrease loss of lean muscle mass in elderly we propose to identify the upper intake of leucine in healthy elderly. The purpose of this study is to determine the tolerable upper intake level (UL) of leucine in healthy elderly men (70 - 75 yrs) The investigators hypothesize that with a careful graded stepwise increase in leucine intake in elderly men, above the Estimated Average Requirement (EAR - 50 mg/kg/d), the body's ability to oxidize/dispose of excess amino acids will reach a maximum. With increased leucine intakes we hypothesize an increase in plasma ammonia concentrations and increases in plasma leucine and urinary leucine excretion.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 19, 2014
CompletedFirst Posted
Study publicly available on registry
March 24, 2014
CompletedStudy Start
First participant enrolled
August 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedJuly 18, 2017
July 1, 2017
10 months
March 19, 2014
July 13, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
13 carbon dioxide production
Urine, plasma and breath samples will be collected during the study to measure the rate of oxidation of the tracer.
8 hours (1 study day)
Study Arms (1)
Leucine intake
EXPERIMENTALDietary supplement: Leucine intake
Interventions
Oral consumption of eight hourly experimental meals- Includes 4 tracer-free experimental meals containing a mixture of free amino acids, calories from a flavored liquid and protein free cookies and 4- labeled amino acid experimental meals.
Eligibility Criteria
You may qualify if:
- Men 70 - 75 years of age
- Free of chronic diseases including; sarcopenia, heart disease, kidney disorders, liver disease, chronic high blood pressure and or diabetes.
- Free of any cognitive disorders
- Men not enrolled in any other research studies
- Men who are not claustrophobic
You may not qualify if:
- Men not within the age 70 -75 years
- Men diagnosed with a chronic diseases including; sarcopenia, heart disease, kidney disorders, liver disease, chronic high blood pressure and/or diabetes
- Men allergic to milk, eggs and egg protein
- Men who are claustrophobic
- Men who are currently enrolled in other research studies
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Child & Family Research Institute
Vancouver, British Columbia, V5Z 4H4, Canada
Related Publications (1)
Rasmussen B, Gilbert E, Turki A, Madden K, Elango R. Determination of the safety of leucine supplementation in healthy elderly men. Amino Acids. 2016 Jul;48(7):1707-16. doi: 10.1007/s00726-016-2241-0. Epub 2016 Apr 30.
PMID: 27138628DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Rajavel Elango, PhD
Child & Family Research Institute/University of British Columbia
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principle Investigator
Study Record Dates
First Submitted
March 19, 2014
First Posted
March 24, 2014
Study Start
August 1, 2014
Primary Completion
June 1, 2015
Study Completion
December 1, 2015
Last Updated
July 18, 2017
Record last verified: 2017-07